Original Research

Published on 13 May 2024

Expression of the apelin receptor, a novel potential therapeutic target, and its endogenous ligands in diverse stem cell populations in human glioblastoma

in Neuropharmacology

Thomas L. Williams
Peter Nwokoye
Rhoda E. Kuc
Kieran Smith
Anna L. Paterson
Kieren Allinson
Janet J. Maguire
Anthony P. Davenport

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1379658

1,477 views
1 citation

Editorial

Published on 10 May 2024

Editorial: Sexual behavior research: towards an understanding of CNS and spinal cord modulation of male sexual behavior and sexual dysfunctions

in Neuropharmacology

Gabriel Gutiérrez-Ospina
Michal Bialy

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1422477

762 views

Original Research

Published on 09 May 2024

Cannabidiol is a behavioral modulator in BTBR mouse model of idiopathic autism

in Neuropharmacology

Sarah H. Shrader
Nicholas Mellen
Jun Cai
Gregory N. Barnes
Zhao-Hui Song

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1359810

1,957 views
2 citations

Review

Published on 07 May 2024

The role of small extracellular vesicles and microRNA as their cargo in the spinal cord injury pathophysiology and therapy

in Neuropharmacology

Kristyna Sintakova
Nataliya Romanyuk

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1400413

1,721 views

Editorial

Published on 07 May 2024

Editorial: Plant-derived natural products: towards novel interventions for neurodegenerative diseases

in Neuropharmacology

Natalia P. Alza
Gabriela A. Salvador
Nora E. Gray
Ginpreet Kaur

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1422351

579 views

Editorial

Published on 02 May 2024

Editorial: Targeting secondary brain damage following intracerebral hemorrhage: from bench to bedside, volume II

in Neuropharmacology

Cheng Gao

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1413483

596 views

Original Research

Published on 30 Apr 2024

Non-motor symptoms associated with progressive loss of dopaminergic neurons in a mouse model of Parkinson’s disease

in Neuropharmacology

Anna Radlicka-Borysewska
Judyta Jabłońska
Michał Lenarczyk
Łukasz Szumiec
Zofia Harda
Monika Bagińska
Justyna Barut
Joanna Pera
Grzegorz Kreiner
Daniel K. Wójcik

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1375265

2,572 views
1 citation

Systematic Review

Published on 25 Apr 2024

Zuranolone for treatment of major depressive disorder: a systematic review and meta-analysis

in Neuropharmacology

Abdullah Ahmad
Abdul Rafeh Awan
Natasha Nadeem
Aamir Shahid Javed
Mobeen Farooqi
Muhammed Daniyal
Hassan Mumtaz

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1361692

2,495 views
1 citation

Original Research

Published on 23 Apr 2024

Probucol mitigates high-fat diet-induced cognitive and social impairments by regulating brain redox and insulin resistance

in Neuropharmacology

Han-Ming Wu
Yang Vivian Yang
Na-Jun Huang
Li-Ping Fan
Ying-Ying Dai
Ke-Ting Hu
Tian-Yu Tang
Lin Liu
Yue Xu
Dong-Tai Liu

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1368552

1,688 views
1 citation

Original Research

Published on 22 Apr 2024

Relationship between depression and sex steroid hormone among women with epilepsy

in Neuropharmacology

Luqman Ogunjimi
Akinyinka Alabi
Ibironke Oyenuga
Jeremiah Ogunkunle
Emmanuel Kasumu
Oluwaseun Ogunsanya
Oluwatobiloba Oluseyije
Pelumi Ogunbayo
Omorojo Idume
Adeola Kasali

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1370533

1,073 views
1 citation

Brief Research Report

Published on 17 Apr 2024

Epigenetic alterations in creatine transporter deficiency: a new marker for dodecyl creatine ester therapeutic efficacy monitoring

in Neuropharmacology

Léa Broca-Brisson
Clémence Disdier
Rania Harati
Rifat Hamoudi
Aloïse Mabondzo

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1362497

1,376 views

Original Research

Published on 09 Apr 2024

Effects of recent cannabis consumption on eye-tracking and pupillometry

in Neuropharmacology

Mohammad N. Haider
Daniel Regan
Mahamudul Hoque
Fahed Ali
Andrew Ilowitz

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1358491

5,431 views
2 citations

Original Research

Published on 25 Mar 2024

Mode of administration influences plasma levels of active Centella asiatica compounds in 5xFAD mice while markers of neuroinflammation remain unaltered

in Neuropharmacology

Alex B. Speers
Kirsten M. Wright
Mikah S. Brandes
Nareg Kedjejian
Donald G. Matthews
Maya Caruso
Christopher J. Harris
Seiji Koike
Thuan Nguyen
Joseph F. Quinn

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1277626

2,014 views
2 citations

Original Research

Published on 21 Mar 2024

Joint-tissue integrative analysis identifies high-risk genes for Parkinson’s disease

in Neuropharmacology

Ya-Shi Wu
Wen-Han Zheng
Tai-Hang Liu
Yan Sun
Yu-Ting Xu
Li-Zhen Shao
Qin-Yu Cai
Ya Qin Tang

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1309684

1,973 views

Original Research

Published on 19 Mar 2024

GABAergic synapses from the ventral lateral septum to the paraventricular nucleus of hypothalamus modulate anxiety

in Neuropharmacology

Ying-Juan Liu
Yan Wang
Jiao-Wen Wu
Jie Zhou
Bai-Lin Song
Yi Jiang
Lai-Fu Li

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1337207

2,015 views

Original Research

Published on 18 Mar 2024

Integrating multi-omics data to reveal the effect of genetic variant rs6430538 on Alzheimer's disease risk

in Neuropharmacology

Shizheng Qiu
Meili Sun
Yanwei Xu
Yang Hu

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1277187

1,593 views
1 citation

Navigation group

Articles

Expression of the apelin receptor, a novel potential therapeutic target, and its endogenous ligands in diverse stem cell populations in human glioblastoma

Editorial: Sexual behavior research: towards an understanding of CNS and spinal cord modulation of male sexual behavior and sexual dysfunctions

Cannabidiol is a behavioral modulator in BTBR mouse model of idiopathic autism

The role of small extracellular vesicles and microRNA as their cargo in the spinal cord injury pathophysiology and therapy

Editorial: Plant-derived natural products: towards novel interventions for neurodegenerative diseases

Editorial: Targeting secondary brain damage following intracerebral hemorrhage: from bench to bedside, volume II

Non-motor symptoms associated with progressive loss of dopaminergic neurons in a mouse model of Parkinson’s disease

Zuranolone for treatment of major depressive disorder: a systematic review and meta-analysis

Probucol mitigates high-fat diet-induced cognitive and social impairments by regulating brain redox and insulin resistance

Relationship between depression and sex steroid hormone among women with epilepsy

Epigenetic alterations in creatine transporter deficiency: a new marker for dodecyl creatine ester therapeutic efficacy monitoring

Effects of recent cannabis consumption on eye-tracking and pupillometry

Mode of administration influences plasma levels of active Centella asiatica compounds in 5xFAD mice while markers of neuroinflammation remain unaltered

Joint-tissue integrative analysis identifies high-risk genes for Parkinson’s disease

GABAergic synapses from the ventral lateral septum to the paraventricular nucleus of hypothalamus modulate anxiety

Integrating multi-omics data to reveal the effect of genetic variant rs6430538 on Alzheimer's disease risk